Meet our CEO Mohammad Afshar in San Diego at the BIO International Convention, held from 23rd to 26th June.
Meet Chief Technology Officer, Mariana Kuras at the European Symposium of Biopathology, held between 19th and 20th June in Paris. She will be speaking on 20th June about Real-time NMR (ExtempoNMR), a new in vitro method of discriminating between cancerous and non-cancerous tissues during surgical procedures- in near real-time conditions.
Meet our CEO, Mohammad Afshar and our VP of Computational Technology, Dave Morley at the latest event in One Nucleus' Life Science Leadership Series: Personalised Medicine. Mohammad will be presenting a talk on "Predictive Diagnostics and Data Mining for Personalised Medicine".
Meet CEO Mohammad Afshar at the 10th annual Biomarkers & Diagnostics World Congress in Philadelphia between 30th April and 2nd May. The conference encompasses all areas of biomarker research in the field of diagnostics and pharmaceuticals.
Discover the ‘Professional Journey of a Physician/ CEO’ in Cambridge, Massachusetts on 26th March. Ariana Pharma is a partner of the ‘Blend of Concept Personality Series Lecture’ with David P. Shenkein, MD, CEO of Agios Pharmaceuticals. Ariana’s Chief Technology Officer, Mariana Kuras will be attending the event. […]
Join us at 7th Oncology Biomarkers, San Diego between 19th and 21st March. CEO Mohammad Afshar will be speaking at 5pm on 20th March on the following: 'Optimal Treatment Selection Tools and Real-time Diagnostics: Towards Multi Component Signature Predictive Software Systems.' Through the media of scientific presentations, case studies and panel discussions, the conference will bring together experts in the oncology biomarker research field to explore and discuss latest developments.
Join us at Big DIP, London between 18th and 20th February to hear from leading Big Data experts- what the 4Vs of Big Data (volume, variety, velocity and veracity) mean for R&D and the marketing of drugs in 2014. Our VP of Computational Technology, Dave Morley will be presenting on the topic 'Improve Clinical Data Analysis to Aid Drug Discovery using Big Data'.
Meet applications scientist Lilia Abtroun at the Techinnov B2B Innovation Meetings in Orly, Paris on the 13th February. Now in it's 8th year, Techinnov is an event dedicated to technology and innovation and will feature the following; business meetings, biotech meetings, R&D meetings, funding meetings, flash presentations, and workshops.
CEO Mohammad Afshar and VP Computational Technology David Morley will be attending the Genesis 2013 conference in London on 12th December. Dr Afshar is a panel member for the Developing Oncology Biomarkers: Lessons from other therapeutic areas session. Dr Morley is presenting our WINTHER press release at the Pre-Genesis BioNewsRound awards on Dec 11th. […]
Ariana Pharma and Voisin Life Sciences Consulting present a conference in Boston on November 12th addressing the topic: Product Development 'What the FDA's Innovative Initiatives enable' Modern approaches for managing the complexity of product development Ariana Pharma and Voisin Consulting Life Science are happy to host a seminar by Frederico Goodsaid, PhD - VP, Strategic Regulatory Intelligence at Vertex Pharmaceuticals and Antoinette Paone, MS - Sr Director, Head of Regulatory Affairs CMC at Vertex, who will discuss in detail the story of the development of Kalydeco. This presentation will be hosted by Mohammad Afshar, CEO of Ariana, and Mark A. De Rosch, PhD - VP, regulatory [...]